Natasha Kyprianou
#133,200
Most Influential Person Now
Researcher ORCID 0000-0002-8713-3599
Natasha Kyprianou's AcademicInfluence.com Rankings
Natasha Kyprianoucomputer-science Degrees
Computer Science
#5967
World Rank
#6292
Historical Rank
Machine Learning
#1784
World Rank
#1807
Historical Rank
Artificial Intelligence
#2031
World Rank
#2065
Historical Rank
Database
#3091
World Rank
#3221
Historical Rank
Download Badge
Computer Science
Natasha Kyprianou's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science Stanford University
- Bachelors Computer Science Stanford University
Similar Degrees You Can Earn
Why Is Natasha Kyprianou Influential?
(Suggest an Edit or Addition)Natasha Kyprianou's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Activation of programmed cell death in the rat ventral prostate after castration. (1988) (736)
- Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. (1990) (513)
- Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. (1991) (448)
- Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. (1993) (416)
- Expression of transforming growth factor-β in the rat ventral prostate during castration-induced programmed cell death (1989) (403)
- Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer. (2010) (333)
- Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration (1989) (297)
- Androgen receptor and growth factor signaling cross-talk in prostate cancer cells. (2008) (266)
- Caspase control: protagonists of cancer cell apoptosis. (2012) (249)
- Effect of transforming growth factor-beta 1 on proliferation and death of rat prostatic cells. (1990) (237)
- Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade. (1997) (228)
- Role of androgens and the androgen receptor in epithelial‐mesenchymal transition and invasion of prostate cancer cells (2010) (215)
- Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. (2001) (210)
- Apoptotic versus proliferative activities in human benign prostatic hyperplasia. (1996) (208)
- bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer. (1998) (194)
- Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance. (2010) (190)
- Activation of a Ca2+−Mg2+‐dependent endonuclease as an early event in castration‐induced prostatic cell death (1988) (189)
- Identification of a cellular receptor for transforming growth factor-beta in rat ventral prostate and its negative regulation by androgens. (1988) (187)
- Androgen regulation of programmed death of normal and malignant prostatic cells. (1992) (186)
- Programmed death of nonproliferating androgen-independent prostatic cancer cells. (1991) (176)
- Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis. (1999) (169)
- Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumor antigen with a recombinant retrovirus. (1991) (162)
- Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis. (2000) (156)
- bcl‐2 over‐expression delays radiation‐induced apoptosis without affecting the clonogenic survival of human prostate cancer cells (1997) (154)
- Induction of prostate apoptosis by doxazosin in benign prostatic hyperplasia. (1998) (150)
- Down‐regulation of protein and mRNA expression for transforming growth factor‐β (TGF‐β1) type I and type II receptors in human prostate cancer (1997) (141)
- Targeting caspases in cancer therapeutics (2013) (140)
- Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells. (1998) (137)
- Targeting anoikis resistance in prostate cancer metastasis. (2010) (134)
- alpha1-ADRENOCEPTOR ANTAGONISTS TERAZOSIN AND DOXAZOSIN INDUCE PROSTATE APOPTOSIS WITHOUT AFFECTING CELL PROLIFERATION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (1999) (130)
- Anoikis and survival connections in the tumor microenvironment: is there a role in prostate cancer metastasis? (2005) (129)
- Apoptosis evasion: The role of survival pathways in prostate cancer progression and therapeutic resistance (2006) (128)
- Diosgenin targets Akt‐mediated prosurvival signaling in human breast cancer cells (2009) (121)
- Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance. (2003) (117)
- Effect of estrogen withdrawal on nitric oxide synthase expression and apoptosis in the rat vagina. (1998) (116)
- "Thymineless" death in androgen-independent prostatic cancer cells. (1989) (115)
- Quinazoline-derived α1-Adrenoceptor Antagonists Induce Prostate Cancer Cell Apoptosis Via an α1-Adrenoceptor-independent Action (2002) (114)
- Incidence of apoptosis and cell proliferation in prostate cancer: Relationship with TGF‐β1 and bcl‐2 expression (1996) (112)
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer (2020) (111)
- Anoikis and EMT: Lethal "Liaisons" during Cancer Progression. (2016) (110)
- Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression (2013) (107)
- Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression. (1996) (106)
- Quinazoline-based α1-adrenoceptor antagonists induce prostate cancer cell apoptosis via TGF-β signalling and IκBα induction (2003) (104)
- Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival. (1999) (103)
- Prohibitin and cofilin are intracellular effectors of transforming growth factor beta signaling in human prostate cancer cells. (2006) (100)
- Androgen Deprivation Therapy for Prostate Cancer Is Associated with Cardiovascular Morbidity and Mortality: A Meta-Analysis of Population-Based Observational Studies (2014) (99)
- Quantal relationship between prostatic dihydrotestosterone and prostatic cell content: Critical threshold concept (1987) (94)
- Doxazosin induces apoptosis of benign and malignant prostate cells via a death receptor-mediated pathway. (2006) (94)
- Androgen Receptor as a Driver of Therapeutic Resistance in Advanced Prostate Cancer (2014) (91)
- Apoptosis in prostate carcinogenesis (2000) (89)
- Live free or die: tales of homeless (cells) in cancer. (2010) (88)
- Mechanisms of Therapeutic Resistance in Prostate Cancer (2017) (88)
- Profiling Prostate Cancer Therapeutic Resistance (2018) (88)
- Cofilin drives cell-invasive and metastatic responses to TGF-β in prostate cancer. (2014) (86)
- Identification of ABR‐215050 as lead second generation quinoline‐3‐carboxamide anti‐angiogenic agent for the treatment of prostate cancer (2006) (86)
- Targeting TGF-β in prostate cancer: therapeutic possibilities during tumor progression (2009) (85)
- Expression of transforming growth factor-beta in the rat ventral prostate during castration-induced programmed cell death. (1989) (83)
- Collagen-induced morphogenesis and expression of the alpha 2-integrin subunit is inhibited in c-erbB2-transfected human mammary epithelial cells. (1993) (82)
- Combined effect of terazosin and finasteride on apoptosis, cell proliferation, and transforming growth factor‐β expression in benign prostatic hyperplasia (2001) (80)
- Growth factor signalling in prostatic growth: significance in tumour development and therapeutic targeting (2006) (79)
- Targeting TGF-beta in prostate cancer: therapeutic possibilities during tumor progression. (2009) (75)
- Multinucleation and Mesenchymal-to-Epithelial Transition Alleviate Resistance to Combined Cabazitaxel and Antiandrogen Therapy in Advanced Prostate Cancer. (2016) (74)
- Activation of programmed cell death by recombinant human tumor necrosis factor plus topoisomerase II-targeted drugs in L929 tumor cells. (1991) (72)
- Induction of prostate apoptosis by α1-adrenoceptor antagonists: mechanistic significance of the quinazoline component (2002) (69)
- Dysfunctional transforming growth factor-beta receptor II accelerates prostate tumorigenesis in the TRAMP mouse model. (2009) (69)
- Significance of talin in cancer progression and metastasis. (2011) (68)
- Apoptosis in prostate carcinogenesis. A growth regulator and a therapeutic target. (2000) (67)
- Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor-independent action. (2002) (66)
- Biological significance of measurable androgen levels in the rat ventral prostate following castration (1987) (66)
- Akt-and CREB-mediated prostate cancer cell proliferation inhibition by Nexrutine, a Phellodendron amurense extract. (2006) (66)
- Inflammation in prostate cancer progression and therapeutic targeting (2015) (62)
- Effect of α1-Adrenoceptor Antagonist Exposure on Prostate Cancer Incidence: An Observational Cohort Study (2007) (62)
- Pharmacological exploitation of the alpha1-adrenoreceptor antagonist doxazosin to develop a novel class of antitumor agents that block intracellular protein kinase B/Akt activation. (2004) (62)
- PARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesis. (2014) (60)
- Mechanisms navigating the TGF-β pathway in prostate cancer (2015) (59)
- Autophagy and oxidative stress in gliomas with IDH1 mutations (2014) (59)
- Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion (2005) (58)
- Genetic instability and the acquisition of metastatic ability by rat mammary cancer cells following v-H-ras oncogene transfection. (1990) (58)
- Effects of Alpha1‐adrenoceptor (α1‐AR) antagonists on cell proliferation and apoptosis in the prostate: Therapeutic implications in prostatic disease (2000) (56)
- Combined antitumor effect of suramin plus irradiation in human prostate cancer cells: the role of apoptosis. (1993) (55)
- Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2. (2003) (55)
- Dihydrotestosterone Enhances Transforming Growth Factor-β-Induced Apoptosis in Hormone-Sensitive Prostate Cancer Cells. (2001) (54)
- N‐terminal targeting of androgen receptor variant enhances response of castration resistant prostate cancer to taxane chemotherapy (2015) (53)
- Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia. (1999) (50)
- Apoptosis and bcl-2 expression in prostate cancer: significance in clinical outcome after brachytherapy. (2001) (49)
- Racial differences in prostate cancer growth: Apoptosis and cell proliferation in Caucasian and African‐American patients (2000) (49)
- Modeling prostate cancer in mice: limitations and opportunities. (2012) (49)
- Down-regulation of protein and mRNA expression for transforming growth factor-beta (TGF-beta1) type I and type II receptors in human prostate cancer. (1997) (49)
- Androgen regulation of epithelial–mesenchymal transition in prostate tumorigenesis (2011) (49)
- Novel quinazoline-based compounds impair prostate tumorigenesis by targeting tumor vascularity. (2007) (49)
- Epithelial-mesenchymal-transition regulators in prostate cancer: Androgens and beyond (2017) (48)
- Inflammation as a Driver of Prostate Cancer Metastasis and Therapeutic Resistance (2020) (48)
- TGF‐β signaling and androgen receptor status determine apoptotic cross‐talk in human prostate cancer cells (2008) (47)
- CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion (2015) (46)
- Radiation-induced apoptosis: predictive and therapeutic significance in radiotherapy of prostate cancer (review). (2000) (45)
- Dysregulation of the mitogen granulin in human cancer through the miR-15/107 microRNA gene group. (2010) (45)
- Prohibitin regulates TGF‐β induced apoptosis as a downstream effector of smad‐dependent and ‐independent signaling (2010) (44)
- Cytoskeleton targeting value in prostate cancer treatment. (2014) (44)
- Profiles of Radioresistance Mechanisms in Prostate Cancer. (2018) (43)
- Maspin sensitizes prostate cancer cells to doxazosin-induced apoptosis (2003) (43)
- Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate. (2004) (43)
- Apoptotic impact of α1‐blockers on prostate cancer growth: A myth or an inviting reality? (2004) (42)
- Induction of apoptosis in androgen‐independent human prostate cancer cells undergoing thymineless death (1994) (40)
- Rare incidence of human papillomavirus types 16 and 18 in primary and metastatic human prostate cancer. (1994) (39)
- Anoikis disruption of focal adhesion-Akt signaling impairs renal cell carcinoma. (2011) (39)
- Transforming growth factor beta and prostate cancer. (2005) (39)
- TGF‐β receptor I inhibitor enhances response to enzalutamide in a pre‐clinical model of advanced prostate cancer (2019) (38)
- Reduction of human prostate tumor vascularity by the α1‐adrenoceptor antagonist terazosin (2001) (38)
- Targeting vasculature in urologic tumors: Mechanistic and therapeutic significance (2008) (38)
- Emerging biomarkers of prostate cancer (Review) (2012) (36)
- The Promise of Novel Molecular Markers in Bladder Cancer (2014) (35)
- Maspin modulates prostate cancer cell apoptotic and angiogenic response to hypoxia via targeting AKT (2008) (35)
- Caspase-1 enhances the apoptotic response of prostate cancer cells to ionizing radiation. (2004) (34)
- Enhanced expression of ICAM-1 in a murine fibrosarcoma reduces tumor growth rate. (1995) (34)
- Exploitation of the Androgen Receptor to Overcome Taxane Resistance in Advanced Prostate Cancer. (2015) (33)
- bcl‐2 antagonizes the combined apoptotic effect of transforming growth factor‐β and dihydrotestosterone in prostate cancer cells (2002) (33)
- Effect of alpha1-adrenoceptor antagonist exposure on prostate cancer incidence: an observational cohort study. (2007) (33)
- Programmed cell death as a new target for prostatic cancer therapy. (1991) (32)
- Prostate tumor neuroendocrine differentiation via EMT: The road less traveled (2018) (32)
- Psoralidin, an Herbal Molecule, Inhibits Phosphatidylinositol 3-Kinase–Mediated Akt Signaling in Androgen-Independent Prostate Cancer Cells (2009) (32)
- Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer. (1998) (32)
- Novel targeting of apoptosis pathways for prostate cancer therapy. (2004) (31)
- Therapeutic value of quinazoline-based compounds in prostate cancer. (2013) (31)
- Effect of permixon on human prostate cell growth: Lack of apoptotic action (2004) (30)
- Advances in the design and synthesis of prazosin derivatives over the last ten years (2011) (30)
- The role of α-blockers in the management of prostate cancer (2004) (28)
- Predictive value of epithelial‐mesenchymal‐transition (EMT) signature and PARP‐1 in prostate cancer radioresistance (2017) (28)
- Novel Pharmacologic Targeting of Tight Junctions and Focal Adhesions in Prostate Cancer Cells (2014) (28)
- Aberrant TGF-&bgr; Signaling Drives Castration-Resistant Prostate Cancer in a Male Mouse Model of Prostate Tumorigenesis (2017) (28)
- Relationship between metastatic ability and H-ras oncogene expression in rat mammary cancer cells transfected with the v-H-ras oncogene. (1990) (27)
- Personalization of prostate cancer therapy through phosphoproteomics (2018) (27)
- Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma (2020) (27)
- Cell proliferation and apoptosis in prostate cancer: significance in disease progression and therapy. (2000) (27)
- Association of epithelial-mesenchymal transition and nuclear cofilin with advanced urothelial cancer. (2016) (25)
- Association states of androgen receptors in nuclei of human benign hypertrophic prostate (1986) (25)
- Finasteride targets prostate vascularity by inducing apoptosis and inhibiting cell adhesion of benign and malignant prostate cells (2006) (24)
- Therapeutic challenges in renal cell carcinoma. (2015) (24)
- EMMPRIN regulates cytoskeleton reorganization and cell adhesion in prostate cancer (2012) (24)
- Detection of microRNAs in prostate cancer cells by microRNA array. (2011) (24)
- Epithelial-mesenchymal transition in prostatic disease. (2015) (23)
- Apoptosis induction by doxazosin and other quinazoline α1-adrenoceptor antagonists: a new mechanism for cancer treatment? (2009) (22)
- Human immunodeficiency virus-1 Tat protein up-regulates interleukin-6 and interleukin-8 expression in human breast cancer cells (2005) (22)
- A tale of two trials: The impact of 5α-reductase inhibition on prostate cancer (Review) (2014) (21)
- Apoptosis: therapeutic significance in the treatment of androgen-dependent and androgen-independent prostate cancer (2004) (21)
- Urologic oncology practice during COVID-19 pandemic: A systematic review on what can be deferrable vs. nondeferrable (2020) (21)
- Apoptotic regulators in prostatic intraepithelial neoplasia (PIN): value in prostate cancer detection and prevention (2005) (20)
- COVID-19 and Kidney Disease: Molecular Determinants and Clinical Implications in Renal Cancer (2020) (20)
- Dihydrotestosterone enhances transforming growth factor-beta-induced apoptosis in hormone-sensitive prostate cancer cells. (2001) (20)
- Proteasomal regulation of caspase-8 in cancer cell apoptosis (2013) (20)
- Transfection of a murine fibrosarcoma with intercellular adhesion molecule-1 enhances the response to adoptive immunotherapy. (1995) (18)
- Partial growth suppression of human prostate cancer cells by the Krev‐1 suppressor gene (1994) (18)
- Radiation-induced apoptosis of human prostate cancer cells is independent of mutant p53 overexpression. (1998) (18)
- The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cells (2014) (17)
- The role of alpha-blockers in the management of prostate cancer. (2004) (17)
- Intracellular death platform steps‐in: Targeting prostate tumors via endoplasmic reticulum (ER) apoptosis (2008) (17)
- The Role of Tumor‐associated Antigens in the Biology and Immunotherapy of Breast Cancer (1993) (16)
- Staging Accuracy of Multiparametric MRI in Caucasian and African American Patients Undergoing Radical Prostatectomy. (2020) (16)
- Sequencing hormonal ablation and radiotherapy in prostate cancer: a molecular and therapeutic prespective (Review). (2002) (15)
- ASK-ing EMT not to spread cancer (2010) (15)
- Induction of apoptosis in the prostate by α1-adrenoceptor antagonists: A novel effect of “Old” drugs (2000) (15)
- Effect of terazosin on tissue vascularity and apoptosis in transitional cell carcinoma of bladder. (2005) (15)
- Alpha1-adrenoceptor antagonists radiosensitize prostate cancer cells via apoptosis induction. (2002) (15)
- Exosomes as A Next-Generation Diagnostic and Therapeutic Tool in Prostate Cancer (2021) (14)
- Isolation of azatyrosine-induced revertants from ras-transformed human mammary epithelial cells. (1992) (14)
- Decreased risk of bladder cancer in men treated with quinazoline-based α1-adrenoceptor antagonists. (2008) (14)
- Reversion of epithelial-mesenchymal transition by a novel agent DZ-50 via IGF binding protein-3 in prostate cancer cells. (2017) (13)
- Association between chronic kidney disease and COVID-19-related mortality in New York (2021) (13)
- Predictive and targeting value of IGFBP-3 in therapeutically resistant prostate cancer. (2019) (12)
- Future concepts in the medical therapy of benign prostatic hyperplasia (2001) (12)
- The Rapid Coronavirus Antibody Test: Can We Improve Accuracy? (2020) (11)
- Activation of TGF-β signalling in human prostate cancer cells suppresses tumorigenicity via deregulation of cell cycle progression and induction of caspase-1 mediated apoptosis: significance in prostate tumorigenesis (1999) (11)
- From Bench to Bedside: How the Tumor Microenvironment Is Impacting the Future of Immunotherapy for Renal Cell Carcinoma (2021) (11)
- The Resilient Child: Sex-Steroid Hormones and COVID-19 Incidence in Pediatric Patients (2020) (9)
- Non-Coding RNAs Set a New Phenotypic Frontier in Prostate Cancer Metastasis and Resistance (2021) (9)
- Evaluation of biopsy techniques for androgen receptor assay in human prostatic tissue. (1986) (9)
- Transient tyrosine phosphorylation of p34cdc2 is an early event in radiation‐induced apoptosis of prostate cancer cells (1997) (9)
- Tumor and Stem Cell Biology Co fi lin Drives Cell-Invasive and Metastatic Responses to TGF-b in Prostate Cancer (2014) (9)
- Therapeutic Approaches to Activating Programmed Cell Death of Androgen-Independent Prostatic Cancer Cells (1991) (9)
- Pseudouridine as a novel biomarker in prostate cancer. (2020) (9)
- Gene fusions find an ERG-way to tumor inflammation (2011) (8)
- Cell death under epithelial–mesenchymal transition control in prostate cancer therapeutic response (2018) (8)
- Impact of COVID-19 on Prostate Cancer Management: Guidelines for Urologists (2020) (8)
- Predictive value of phenotypic signatures of bladder cancer response to cisplatin-based neoadjuvant chemotherapy. (2019) (8)
- Development of androgen-independent tumor cells and their implication for the treatment of prostatic cancer (2004) (8)
- POTENT IN VITRO ANTICANCER ACTIVITIES OF RING-EXPANDED (“FAT”) NUCLEOSIDES CONTAINING THE IMIDAZO[4,5-E][1,3]DIAZEPINE RING SYSTEM (2001) (8)
- Molecular Exploitation of Apoptosis Pathways in Prostate Cancer (2012) (8)
- Biological basis for chemohormonal therapy for prostatic cancer. (1989) (7)
- Reversion of epithelial-mesenchymal transition by a novel agent DZ-50 via IGF binding protein-3 in prostate cancer cells (2017) (7)
- Small Molecule, Multimodal, [18F]-PET and Fluorescence Imaging Agent Targeting Prostate-Specific Membrane Antigen: First-in-Human Study. (2021) (7)
- Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis (2022) (6)
- Cancer esearch apeutics , Targets , and Chemical Biology ulin-Targeting Chemotherapy Impairs Androgen R eptor Activity in Prostate Cancer (2010) (6)
- Androgen Receptor Signaling Interactions Control Epithelial–Mesenchymal Transition (EMT) in Prostate Cancer Progression (2013) (6)
- Impact of α-adrenoceptor antagonists on prostate cancer development, progression and prevention. (2019) (6)
- Impact of Circadian Rhythms on the Development and Clinical Management of Genitourinary Cancers (2022) (5)
- Molecular tracing of prostate cancer lethality (2020) (5)
- Early mortality risk stratification after SARS-CoV-2 infection (2020) (5)
- Androgens modify therapeutic response to cabazitaxel in models of advanced prostate cancer (2020) (5)
- Integrin-associated CD151 is a suppressor of prostate cancer progression. (2020) (5)
- Embryologic and hormonal contributors to prostate cancer in transgender women. (2022) (4)
- Extracellular vesicles carry distinct proteo-transcriptomic signatures that are different from their cancer cell of origin (2021) (4)
- Reversion of human prostate tumorigenic growth by azatyrosine. (1995) (4)
- The Fringe Benefits of Cloning Cancer (2014) (4)
- Does gender matter in academic surgery? Author and mentor gender impact publication citations in surgical research. (2021) (4)
- Molecular Signatures in Urologic Tumors (2013) (4)
- Performance of prostate multiparametric MRI for prediction of prostate cancer extraprostatic extension according to NCCN risk categories: implication for surgical planning. (2020) (4)
- The Evolving Clinical Management of Genitourinary Cancers Amid the COVID-19 Pandemic (2021) (3)
- SARS-CoV-2 RNA Detected in Abdominal Insufflation Samples During Laparoscopic Surgery (2021) (3)
- Dynamic plasticity of prostate cancer intermediate cells during androgen receptor-targeted therapy. (2022) (3)
- Circadian Rhythm Disruption as a Contributor to Racial Disparities in Prostate Cancer (2022) (3)
- Cancer Cells Signaling in Human Prostate β Transforming Growth Factor Prohibitin and Cofilin Are Intracellular Effectors of Updated (2006) (3)
- Induction of apoptosis by alpha1-adrenoceptor antagonists in benign prostatic hyperplasia and prostate cancer. (2000) (3)
- Intranuclear distribution of androgen receptors in human prostate carcinoma. (1987) (3)
- Adipose tissue: enabler of prostate cancer aggressive behavior. (2019) (2)
- CELL BIOLOGY AND SIGNALING (2010) (2)
- New approaches to the evaluation of the metastatic ability of renal cancer and new approaches to chemotherapy. (1990) (2)
- MUTANT IDH1 SUPPRESSES APOPTOSIS REGULATOR PAR-4 IN GLIOMAS (2014) (2)
- Prostate cancer in transgender women: considerations for screening, diagnosis and management (2022) (2)
- What Stone-formers Should Know About Vitamin C and D Supplementation in the COVID-19 Era (2020) (2)
- PROSTATE TISSUE EFFECTS OF SAW PALMETTO EXTRACT IN MEN WITH SYMPTOMATIC BPH (1999) (2)
- Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease (2021) (2)
- GRM1 is An Androgen-Regulated Gene and its Expression Correlates with Prostate Cancer Progression in Pre-Clinical Models. (2016) (2)
- TGF-β signaling dictates therapeutic targeting in prostate cancer (2008) (2)
- Expression patterns of epithelial–mesenchymal transition markers in localized prostate cancer: significance in clinicopathological outcomes following radical prostatectomy (2013) (2)
- Repurposing of α1-Adrenoceptor Antagonists: Impact in Renal Cancer (2020) (2)
- TGF-β Conveys Undesirable Side Effects of Androgen Depletion. (2016) (2)
- Prostate cancer: Kinases and CHIPS sign-off personalization of therapy (2016) (1)
- TALIN1 IS A NOVEL MEDIATOR OF PROSTATE CANCER CELL MIGRATION, INVASION, AND METASTASIS (2008) (1)
- Featured Review Article Cytoskeleton targeting value in prostate cancer treatment (2014) (1)
- 127: Effect of α1-Adrenoceptor Antagonists on Prostate Cancer Incidence: A Retrospective Analysis (2006) (1)
- Integrated Therapeutic Targeting of the Prostate Tumor Microenvironment. (2020) (1)
- COVID-19 in patients with and without cancer: Examining differences in patient characteristics and outcomes (2021) (1)
- Talin1 Promotes Prostate Cancer Invasion and Metastasis via AKT Signaling and Anoikis Resistance (2009) (1)
- EFFECT OF DOXAZOSIN MEDIATED ALPHA -1 BLOCKADE ON TGF-beta AND p27 EXPRESSION IN BENIGN PROSTATIC HYPERPLASIA (1999) (1)
- Pathophysiology of Castration-Resistant Prostate Cancer (2016) (1)
- Induction of apoptosis by α1-adrenoceptor antagonists in benign prostatic hyperplasia and prostate cancer (2000) (1)
- RIPK2 Stabilizes c-Myc and is an Actionable Target for Inhibiting Prostate Cancer Metastasis (2020) (1)
- Emmprin is a Biomarker of Prostate Cancer Progression in TRAMP Mice (2007) (1)
- COVID-19 vaccination: Prioritization of at risk groups (2021) (1)
- Association between Chronic Kidney Disease and COVID-19 Related Mortality in New York (2020) (1)
- 1094: Decreased Risk for Bladder Cancer in Men Treated with Quinazoline-A1-Adrenoceptor Antagonists (2007) (0)
- Abstract 2122: Pharmacologic interconversion of EMT to MET for prostate cancer (2017) (0)
- Epigenetic mechanisms underlying subtype heterogeneity and tumor recurrence in prostate cancer (2023) (0)
- Androgen Receptor Regulation by Microtubule‐targeting Chemotherapeutics in Prostate Cancer (2012) (0)
- Association between Expression of Connective Tissue Genes and Prostate Cancer Growth and Progression (2023) (0)
- Proteasomal regulation of caspase-8 in cancer cell apoptosis (2013) (0)
- PHARMACOLOGIC TARGETING OF TGF‐&bgr; MEDIATED EMT IN PROSTATE CANCER: PD33‐03 (2017) (0)
- Social Determinants Contribute to Disparities in Test Positivity, Morbidity and Mortality: Data from a Multi-Ethnic Cohort of 1094 GU Cancer Patients Undergoing Assessment for COVID-19 (2022) (0)
- Apoptosis and Cell Cycle Deregulation in Prostate Cancer (2003) (0)
- Introduction: Prostate Cancer (2012) (0)
- Role of Apoptosis in Prostate Cancer Prevention (2012) (0)
- Programmed Cell Death during Regression of PC-82 Human Prostate Cancer following Androgen Ablation 1 (2006) (0)
- Biological Significance of Measurable Dihydrotestosterone (DHT) Levels in the Prostate Following Castration (1987) (0)
- Epithelial–Mesenchymal Transition (EMT) in Prostate Cancer Metastasis (2012) (0)
- PL3-2 TGF-β and androgen signaling cross-talk regulates apoptosis and epithelial-mesenchymal-transition (EMT) in prostate cancer (2010) (0)
- The Prostate Gland Dynamics (2012) (0)
- Adult UrologyOncology: Prostate/Testis/Penis/UrethraEditorial Comment (2009) (0)
- 581: The Effect of Terazosin on Apoptosis and Tissue Vascularity in Transitional Cell Carcinoma of the Bladder (2005) (0)
- Value of multiphoton microscopy in uro-oncology: a narrative review (2023) (0)
- Erratum: Diosgenin targets akt-mediated pro-survival signaling in human breast cancer cells (International Journal of Cancer (2009) 125:4 (961-967) DOI: 10.1002/ijc.24419) (2015) (0)
- Mitochondrial H2O2 Defines Redox Heterogeneity in Radiation Resistant Prostate Cancer (2020) (0)
- Induction of Prostate Apoptosis in Response to α1-Adrenoceptor Antagonists: Therapeutic Significance in Benign Prostatic Hyperplasia and Prostate Cancer (1999) (0)
- NOVEL BIOMARKER SIGNATURE FOR PREDICTING PATHOLOGIC RESPONSE OF UROTHELIAL CARCINOMA OF THE BLADDER TO CISPLATIN‐BASED NEOADJUVANT CHEMOTHERAPY: MP65‐16 (2018) (0)
- Abstract 4969: Impact of proteasome inhibition of caspase-8 regulation in cancer (2012) (0)
- Therapeutic targeting of α- and β-adrenergic signaling for urologic diseases (2021) (0)
- Angiogenesis & Therapeutic Targets In Cancer (2012) (0)
- Apoptosis Pathways Signaling Execution of Cancer Cells (2012) (0)
- Anoikis in Prostate Cancer Metastasis (2012) (0)
- Comprar Molecular Exploitation Of Apoptosis Pathways In Prostate Cancer (Molecular Medicine And Medicinal Chemistry - Vol. 4) | Natasha Kyprianou | 9781848164499 | Imperial College Press (2011) (0)
- Original Articles INDUCTION OF PROSTATE APOPTOSIS BY DOXAZOSIN IN BENIGN PROSTATIC HYPERPLASM (1998) (0)
- Effects of v-H- ras on Immortalized Non-Tumorigenic Human Mammary Epithelial Cells (1991) (0)
- Human hepatocellular carcinoma tumor xenografts (1988) (0)
- The differential effects of adrenoceptor antagonists on prostate tissue growth (2005) (0)
- Summary and Future Directions (2012) (0)
- PD14-02 OVERCOMING RESISTANCE TO ANTIANDROGENS VIA TARGETING IGBP3 IN PROSTATE CANCER (2018) (0)
- Therapeutic Significance of Apoptosis in the Treatment of Androgen-Dependent and Androgen-Independent Prostate Cancer (1995) (0)
- Characterization of prostate cancer in transgender women (2023) (0)
- Age-Related Differences in Clinical and Psychosocial Predictors of Unmet Needs in Bladder Cancer Survivors (2021) (0)
- Retraction: GRM1 is An Androgen-Regulated Gene and its Expression Correlates with Prostate Cancer Progression in Pre-Clinical Models (2017) (0)
- Androgen Receptor-Mediated Apoptosis: Significance in Development of Castration Resistant Prostate Cancer (2012) (0)
- Apoptotic-Based Molecular Markers of Therapeutic Response (2012) (0)
- Abstract 2567: Cabazitaxel chemotherapy targets mitotic kinesins resulting in multi-nucleation of prostate cancer cells: A novel mechanism of cross-resistance with antiandrogens in advanced CRPC (2015) (0)
- Multiphoton Microscopy for Identifying Collagen Signatures Associated with Biochemical Recurrence in Prostate Cancer Patients (2021) (0)
- Anoikis in phenotypic reprogramming of the prostate tumor microenvironment (2023) (0)
- WITHDRAWN: Mechanisms navigating the TGF-β pathway in prostate cancer (2014) (0)
- AUTHOR REPLY (2021) (0)
- Programmed Cell Death during Regression of PC-82 Human Prostate Cancer following Androgen Ablation1 (2006) (0)
- p27 Stands-up-to-cancer: UPS nuclear service stops. (2013) (0)
- MP23-10 ASSESSING RENAL DAMAGE CAUSED BY NEW HIGH POWER LASERS DURING URETEROSCOPIC LASER LITHOTRIPSY: A RANDOMIZED TRIAL (2023) (0)
- Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma (2020) (0)
- When to order genomic tests: development and external validation of a model to predict high-risk prostate cancer at the genotypic level (2021) (0)
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer (2020) (0)
- Nuclear spindles pave the way to metastasis (2017) (0)
- The role of connective tissue in prostate cancer growth and progression (2020) (0)
- Understanding the link between kidney stones and cancers of the upper urinary tract and bladder. (2022) (0)
- Pathophysiologyof Castration-Resistant Prostate Cancer (2017) (0)
- Human immunodeficiency virus-1 Tat protein upregulates IL-6 and IL-8 expression in human breast cancer cells (2004) (0)
- Transforming Growth Factor‐β and Cancer (2007) (0)
- RESTORATION OF TGF-beta SIGNALING PATHWAY IN HUMAN PROSTATE CANCER CELLS SUPPRESSES TUMORIGENICITY VIA INDUCTION OF CASPASE-1-MEDIATED APOPTOSIS (1999) (0)
- Emerging therapeutics targeting castration-resistant prostate cancer: the AR-mageddon of tumor epithelial–mesenchymal transition (2013) (0)
- Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease (2021) (0)
- DOXAZOSIN REGULATES GROWTH OF HUMAN PROSTATE SMOOTH MUSCLE AND PROSTATE CANCER CELLS BY INDUCING APOPTOSIS (1999) (0)
- EFFECT OF FINASTERIDE AND TERAZOSIN ON APOPTOTIC AND PROLIFERATIVE INDICES IN BENIGN PROSTATIC HYPERPLASIA (1999) (0)
- The Benef ts of Cloning Cancer (2016) (0)
- Emerging approaches to target mitochondrial apoptosis in cancer cells (2019) (0)
- Biomarker Discovery and Mechanistic Studies of Prostate Cancer Using Targeted Proteomic Approaches PRINCIPAL INVESTIGATOR: (2013) (0)
- QUINAZOLINE-MEDIATED ANOIKIS IN RENAL CELL CARCINOMA VIA DISRUPTION OF FOCAL ADHESION DEPENDENT AKT SURVIVAL SIGNALING (2008) (0)
- Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis (2022) (0)
- 1440 EFFECT OF EXERCISE ON PROSTATE CANCER IN THE TRANSGENIC ADENOCARCINOMA OF THE MOUSE PROSTATE (TRAMP) MODEL (2010) (0)
- MP09-09 USING BIOMARKERS IN PATIENTS WITH A POSITIVE MPMRI. 4KSCORE PREDICTS PRESENCE OF CANCER OUTSIDE THE INDEX LESION (2020) (0)
- Novel Molecular Therapeutics for Targeting Castration-Resistant Prostate Cancer (2012) (0)
- Overcoming resistance to antiandrogens with a TGF-β RI inhibitor in preclinical mouse model of PCa. (2018) (0)
- Doxazosin‐derived DZ‐3 Compound Enhances Apoptotic Ability of Maspin‐sensitized Prostate Cancer Cells (2007) (0)
- Activation of programmed cell death in androgen dependent and androgen independent prostatic tumors (1989) (0)
- Prostate MRI percentage tumor involvement or “PI‐RADS percent” as a predictor of adverse surgical pathology (2022) (0)
- Potent in vitro Anticancer Activities of Ring‐Expanded (“fat”) Nucleosides Containing the Imidazo[4,5‐E][1,3]diazepine Ring System (2001) (0)
- Re: Regenerative Potential of Prostate Luminal Cells Revealed by Single-cell Analysis. (2020) (0)
- Deciphering Evolutionary Dynamics and Lineage Plasticity in Aggressive Prostate Cancer (2021) (0)
- Homeless Cells Escape Death and Deliver Lethal Cancer (2021) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Natasha Kyprianou?
Natasha Kyprianou is affiliated with the following schools:
